US20020192198A1
(en)
*
|
1998-04-21 |
2002-12-19 |
Elia James P. |
Method for growing human organs and suborgans
|
US20030157074A1
(en)
*
|
1994-11-16 |
2003-08-21 |
Mitrani Eduardo N. |
Vitro micro-organs, and uses related thereto
|
US5980887A
(en)
*
|
1996-11-08 |
1999-11-09 |
St. Elizabeth's Medical Center Of Boston |
Methods for enhancing angiogenesis with endothelial progenitor cells
|
US8075880B2
(en)
|
1999-01-11 |
2011-12-13 |
Steward St. Elizabeth's Medical Center Of Boston, Inc. |
Compositions and methods for regulating angiogenesis
|
ATE296117T1
(de)
|
1997-03-07 |
2005-06-15 |
Wistar Inst |
Verwendung von adenoviralen vektoren, die pdgf oder vegf exprimieren, zur heilung von gewebsdefekten und zur induzierung der hypervaskulität in säugergeweben
|
DK1019082T4
(da)
*
|
1997-10-02 |
2008-10-27 |
Max Planck Gesellschaft |
Fremgangsmåde til moduleringen af neovaskularisering og/eller væksten af kollaterale arterier og/eller andre arterier fra forudeksisterende arteriolære forbindelser
|
US6749617B1
(en)
|
1997-11-04 |
2004-06-15 |
Scimed Life Systems, Inc. |
Catheter and implants for the delivery of therapeutic agents to tissues
|
US7687057B2
(en)
*
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
JP2002500879A
(ja)
*
|
1998-01-23 |
2002-01-15 |
イムクローン システムズ インコーポレーテッド |
幹細胞の精製ポピュレーション
|
WO1999045775A1
(en)
*
|
1998-03-09 |
1999-09-16 |
St. Elizabeth's Medical Center |
Compositions and methods for modulating vascularization
|
US20040228834A1
(en)
*
|
1998-03-09 |
2004-11-18 |
Jeffrey Isner |
Compositions and methods for modulating vascularization
|
US6676937B1
(en)
*
|
1998-03-09 |
2004-01-13 |
Caritas St. Elizabeth's Medical Center Of Boston Inc. |
Compositions and methods for modulating vascularization
|
US6482406B1
(en)
|
1999-03-26 |
2002-11-19 |
Duncan J. Stewart |
Cell-based gene therapy for the pulmonary system
|
CA2266805C
(en)
|
1998-03-27 |
2015-04-28 |
An-Go-Gen Inc. |
Cell-based gene therapy in the treatment of pulmonary disorders
|
US9585916B2
(en)
|
1999-03-26 |
2017-03-07 |
Northern Therapeutics Inc. |
Cell based therapy for the pulmonary system
|
US6620382B1
(en)
|
1998-05-22 |
2003-09-16 |
Biopheresis Technologies, Llc. |
Method and compositions for treatment of cancers
|
US8197430B1
(en)
|
1998-05-22 |
2012-06-12 |
Biopheresis Technologies, Inc. |
Method and system to remove cytokine inhibitor in patients
|
US6352555B1
(en)
|
1998-07-10 |
2002-03-05 |
The Brigham And Womens Hospital, Inc. |
Methods for implanting cells
|
US6677300B1
(en)
*
|
1998-09-09 |
2004-01-13 |
Scios, Inc. |
Treatment of microvascular angiopathies
|
US7030083B2
(en)
*
|
1998-09-09 |
2006-04-18 |
University Of Washington |
Treatment of eclampsia and preeclampsia
|
US6958147B1
(en)
|
1998-10-26 |
2005-10-25 |
Licentia Ltd |
Use of VEGF-C to prevent restenosis
|
PT1126870E
(pt)
*
|
1998-10-26 |
2005-01-31 |
Licentia Ltd |
Utilizacao do gene vegf-c ou vegf-d ou de uma proteina na prevencao da restenose
|
EP1568375A1
(en)
*
|
1998-10-26 |
2005-08-31 |
Ludwig Institute For Cancer Research |
Use of VEGF-C or VEGF-D gene or protein to prevent restenosis
|
DE19850986A1
(de)
*
|
1998-11-05 |
2000-05-25 |
Aventis Pharma Gmbh |
Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen
|
CA2351671A1
(en)
*
|
1998-11-24 |
2000-06-08 |
Regents Of The University Of Minnesota |
Transgenic circulating endothelial cells
|
US20040131601A1
(en)
*
|
2000-03-30 |
2004-07-08 |
Foundry Networks, Inc., A Delaward Corporation |
Injection of bone marrow-derived cells and medium for angiogenesis
|
US6348050B1
(en)
*
|
1999-04-30 |
2002-02-19 |
Medtronic, Inc. |
Infusion systems for creating microenvironments in a living body
|
US20030152562A1
(en)
*
|
2001-10-23 |
2003-08-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Vitro micro-organs, and uses related thereto
|
US8062675B2
(en)
*
|
1999-07-07 |
2011-11-22 |
Angioblast Systems, Inc. |
Mesenchymal precursor cell
|
AUPQ147799A0
(en)
|
1999-07-07 |
1999-07-29 |
Medvet Science Pty. Ltd. |
Mesenchymal precursor cell
|
US20050158289A1
(en)
*
|
1999-07-07 |
2005-07-21 |
Simmons Paul J. |
Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
|
AU2003901668A0
(en)
*
|
2003-03-28 |
2003-05-01 |
Medvet Science Pty. Ltd. |
Non-haemopoietic precursor cells
|
US7670628B2
(en)
*
|
1999-07-07 |
2010-03-02 |
Angioblast Systems, Inc. |
Mesenchymal precursor cell
|
US20020193301A1
(en)
|
1999-08-19 |
2002-12-19 |
Stem Cell Pharmaceuticals, Inc. |
TGF-alpha polypeptides, functional fragments and methods of use therefor
|
CA2380635A1
(en)
*
|
1999-08-19 |
2001-02-22 |
Stem Cell Pharmaceuticals, Inc. |
Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
|
CA2383093A1
(en)
*
|
1999-09-23 |
2001-03-29 |
An-Go-Gen Inc. |
Cell-based gene therapy for the pulmonary system
|
ATE409494T1
(de)
*
|
1999-10-29 |
2008-10-15 |
Anges Mg Inc |
Gentherapie für diabetische ischämie
|
US6379708B1
(en)
*
|
1999-11-20 |
2002-04-30 |
Cytologic, Llc |
Method for enhancing immune responses in mammals
|
US9522217B2
(en)
*
|
2000-03-15 |
2016-12-20 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
US20070055367A1
(en)
*
|
2000-03-15 |
2007-03-08 |
Orbus Medical Technologies, Inc. |
Medical device with coating that promotes endothelial cell adherence and differentiation
|
KR100860860B1
(ko)
|
2000-03-15 |
2008-09-29 |
오르버스네이치 메디칼 인코포레이티드 |
내피 세포 부착을 촉진하는 코팅
|
US20030229393A1
(en)
*
|
2001-03-15 |
2003-12-11 |
Kutryk Michael J. B. |
Medical device with coating that promotes cell adherence and differentiation
|
US8460367B2
(en)
*
|
2000-03-15 |
2013-06-11 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
US8088060B2
(en)
*
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
US20030104977A1
(en)
*
|
2000-03-31 |
2003-06-05 |
Ugo Ripamonti |
Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
|
US20100303769A1
(en)
*
|
2000-04-06 |
2010-12-02 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
US20050277576A1
(en)
*
|
2000-04-06 |
2005-12-15 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
US10281478B2
(en)
|
2000-04-06 |
2019-05-07 |
Wayne P. Franco |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
US9694038B2
(en)
*
|
2000-04-06 |
2017-07-04 |
Wayne P. Franco |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
US7166280B2
(en)
*
|
2000-04-06 |
2007-01-23 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
US20070111935A1
(en)
*
|
2000-04-06 |
2007-05-17 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
US6800298B1
(en)
*
|
2000-05-11 |
2004-10-05 |
Clemson University |
Biological lubricant composition and method of applying lubricant composition
|
WO2001094420A1
(en)
*
|
2000-06-05 |
2001-12-13 |
The Trustees Of Columbia University In The City Of New York |
Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
|
CA2429502A1
(en)
*
|
2000-07-26 |
2002-01-31 |
Scimed Life Systems, Inc. |
Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
|
EP1383551B1
(en)
*
|
2000-11-08 |
2010-07-14 |
Boston Scientific Limited |
Multilumen catheter and implants for the delivery of therapeutic agents to tissues
|
US7824680B2
(en)
*
|
2001-08-06 |
2010-11-02 |
The Regents Of The University Of California |
Methods for inhibiting angiogenesis
|
CA2457694A1
(en)
*
|
2001-08-09 |
2003-02-20 |
Cornell Research Foundation, Inc. |
Platelet-derived growth factor protection of cardiac myocardium
|
US7217570B2
(en)
*
|
2001-08-23 |
2007-05-15 |
The Wistar Institute Of Anatomy And Biology |
Organotypic intestinal culture and methods of use thereof
|
US20030054331A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Stemsource, Inc. |
Preservation of non embryonic cells from non hematopoietic tissues
|
US20040031067A1
(en)
*
|
2001-10-11 |
2004-02-12 |
Meenhard Herlyn |
Regulation of human skin healing
|
US20040044403A1
(en)
*
|
2001-10-30 |
2004-03-04 |
Joyce Bischoff |
Tissue-engineered vascular structures
|
EP1441656A1
(en)
*
|
2001-11-05 |
2004-08-04 |
Medgenics, Inc. |
Method and apparatus for production of a skin graft and the graft produced thereby
|
US8608661B1
(en)
|
2001-11-30 |
2013-12-17 |
Advanced Cardiovascular Systems, Inc. |
Method for intravascular delivery of a treatment agent beyond a blood vessel wall
|
US8105580B2
(en)
|
2001-12-07 |
2012-01-31 |
Cytori Therapeutics, Inc. |
Methods of using adipose derived stem cells to promote wound healing
|
US20050008626A1
(en)
*
|
2001-12-07 |
2005-01-13 |
Fraser John K. |
Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
|
US7585670B2
(en)
*
|
2001-12-07 |
2009-09-08 |
Cytori Therapeutics, Inc. |
Automated methods for isolating and using clinically safe adipose derived regenerative cells
|
US7595043B2
(en)
*
|
2001-12-07 |
2009-09-29 |
Cytori Therapeutics, Inc. |
Method for processing and using adipose-derived stem cells
|
JP4653952B2
(ja)
*
|
2001-12-07 |
2011-03-16 |
サイトリ セラピューティクス インコーポレイテッド |
処理済み脂肪吸引細胞で患者を治療するためのシステムと方法
|
US7771716B2
(en)
|
2001-12-07 |
2010-08-10 |
Cytori Therapeutics, Inc. |
Methods of using regenerative cells in the treatment of musculoskeletal disorders
|
US7514075B2
(en)
*
|
2001-12-07 |
2009-04-07 |
Cytori Therapeutics, Inc. |
Systems and methods for separating and concentrating adipose derived stem cells from tissue
|
US8404229B2
(en)
*
|
2001-12-07 |
2013-03-26 |
Cytori Therapeutics, Inc. |
Methods of using adipose derived stem cells to treat acute tubular necrosis
|
US20050095228A1
(en)
*
|
2001-12-07 |
2005-05-05 |
Fraser John K. |
Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
|
US20060204556A1
(en)
*
|
2001-12-07 |
2006-09-14 |
Cytori Therapeutics, Inc. |
Cell-loaded prostheses for regenerative intraluminal applications
|
US9597395B2
(en)
|
2001-12-07 |
2017-03-21 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
|
US7651684B2
(en)
|
2001-12-07 |
2010-01-26 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
|
JP2005518828A
(ja)
*
|
2001-12-20 |
2005-06-30 |
マクロポア インコーポレイテッド |
脂肪組織から抽出したコラーゲンに富む物質を用いた患者を治療するためのシステム及び方法
|
JP2005514062A
(ja)
*
|
2001-12-21 |
2005-05-19 |
イミュネックス・コーポレーション |
内皮幹細胞、該細胞集団、該細胞の単離法および使用法
|
US20030139333A1
(en)
*
|
2002-01-18 |
2003-07-24 |
Genetix Pharmaceuticals, Inc. |
Methods and compositions for promoting angiogenesis
|
US20040009146A1
(en)
*
|
2002-02-26 |
2004-01-15 |
Osvaldo Podhajcer |
Anti-tumor vaccine and method
|
US20030199464A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Silviu Itescu |
Regeneration of endogenous myocardial tissue by induction of neovascularization
|
US7361368B2
(en)
|
2002-06-28 |
2008-04-22 |
Advanced Cardiovascular Systems, Inc. |
Device and method for combining a treatment agent and a gel
|
US20040009158A1
(en)
*
|
2002-07-11 |
2004-01-15 |
Washington University |
Promotion of neovascularization using bone marrow-derived endothelial-progenitor cells
|
US20040052771A1
(en)
*
|
2002-07-12 |
2004-03-18 |
Lim Sai Kiang |
Hemangioblast progenitor cells
|
US20060165666A1
(en)
*
|
2002-07-12 |
2006-07-27 |
Lim Sai K |
Hemangioblast progenitor cells
|
JP2005533102A
(ja)
*
|
2002-07-12 |
2005-11-04 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム |
微小器官によって生物学的プロセスを誘発する方法と装置
|
DE10234192B4
(de)
*
|
2002-07-26 |
2009-11-26 |
Epoplus Gmbh Co.Kg |
Verwendung von Erythropoetin
|
US20050271639A1
(en)
*
|
2002-08-22 |
2005-12-08 |
Penn Marc S |
Genetically engineered cells for therapeutic applications
|
WO2008121719A1
(en)
|
2007-03-30 |
2008-10-09 |
The Cleveland Clinic Foundation |
Method of treating ischemic disorders
|
US20040037811A1
(en)
*
|
2002-08-22 |
2004-02-26 |
The Cleveland Clinic Foundation |
Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
|
US7470538B2
(en)
*
|
2002-12-05 |
2008-12-30 |
Case Western Reserve University |
Cell-based therapies for ischemia
|
US20040258670A1
(en)
*
|
2002-12-05 |
2004-12-23 |
Case Western Reserve University |
Cell-based therapies for ischemia
|
US7060684B1
(en)
|
2002-12-16 |
2006-06-13 |
Quijano Rodolfo C |
Device for treating diabetes and methods thereof
|
US8940292B2
(en)
|
2003-01-28 |
2015-01-27 |
Wake Forest University Health Sciences |
Enhancement of angiogenesis to grafts using cells engineered to produce growth factors
|
US20040197310A1
(en)
*
|
2003-02-12 |
2004-10-07 |
Sanberg Paul R. |
Compositions and methods for using umbilical cord progenitor cells in the treatment of myocardial infarction
|
EP1615996A4
(en)
*
|
2003-03-27 |
2006-11-15 |
Texase A & M University System |
USES OF VEGETABLE TOTHELIC GROWTH FACTOR AND COLLAGEN INDUCIBLE PROTEIN TYPE I (VCIP)
|
US7641643B2
(en)
|
2003-04-15 |
2010-01-05 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
US8038991B1
(en)
|
2003-04-15 |
2011-10-18 |
Abbott Cardiovascular Systems Inc. |
High-viscosity hyaluronic acid compositions to treat myocardial conditions
|
US8821473B2
(en)
|
2003-04-15 |
2014-09-02 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
US20040247575A1
(en)
*
|
2003-06-03 |
2004-12-09 |
Caplice Noel M. |
Smooth muscle progenitor cells
|
SG146666A1
(en)
*
|
2003-09-17 |
2008-10-30 |
Macropore Biosurgery Inc |
Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
|
US9403908B2
(en)
*
|
2003-09-29 |
2016-08-02 |
The Regents Of The University Of California |
Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration
|
US8465453B2
(en)
*
|
2003-12-03 |
2013-06-18 |
Mayo Foundation For Medical Education And Research |
Kits, apparatus and methods for magnetically coating medical devices with living cells
|
US20090118817A1
(en)
*
|
2005-06-16 |
2009-05-07 |
Mayo Foundation For Medical Education And Research |
Magnetic Medical Apparatus, Kits, and Methods
|
DE102004004509B4
(de)
*
|
2004-01-23 |
2010-07-01 |
Epoplus Gmbh Co.Kg |
Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden
|
JP2007217283A
(ja)
*
|
2004-03-30 |
2007-08-30 |
Niigata Tlo:Kk |
血管新生促進剤および血管新生療法
|
KR20070008714A
(ko)
*
|
2004-04-30 |
2007-01-17 |
오르버스네이치 메디칼 인코포레이티드 |
유전적으로-변형된 세포 포획용 코팅을 갖는 의료 장치 및이의 사용 방법
|
WO2005113751A1
(en)
|
2004-05-14 |
2005-12-01 |
Becton, Dickinson And Company |
Cell culture environments for the serum-free expansion of mesenchymal stem cells
|
PL1759536T3
(pl)
|
2004-06-01 |
2011-10-31 |
Kwalata Trading Ltd |
Techniki in vitro z użyciem komórek macierzystych
|
US20060035290A1
(en)
*
|
2004-08-13 |
2006-02-16 |
Medtronic, Inc. |
Isolation of endothelial progenitor cell subsets and methods for their use
|
AU2005287855B2
(en)
*
|
2004-09-24 |
2011-06-16 |
Mesoblast, Inc. |
Method of enhancing proliferation and/or survival of mesenchymal precursor cells (MPC)
|
AU2005291810B2
(en)
*
|
2004-10-07 |
2011-12-08 |
Stem Cell Therapeutics Corp. |
Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
|
EP1827494A4
(en)
*
|
2004-11-18 |
2010-02-17 |
Wayne Franco |
COMBINATION GROWTH THERAPY AND CELL THERAPY FOR THE TREATMENT OF ACUTE AND CHRONIC ORGANIC DISEASES
|
US20060110374A1
(en)
*
|
2004-11-24 |
2006-05-25 |
Dudy Czeiger |
Method to accelerate stem cell recruitment and homing
|
WO2006060779A2
(en)
*
|
2004-12-03 |
2006-06-08 |
Case Western Reserve University |
Novel methods, compositions and devices for inducing neovascularization
|
US20080140451A1
(en)
*
|
2005-01-10 |
2008-06-12 |
Cytori Therapeutics, Inc. |
Devices and Methods for Monitoring, Managing, and Servicing Medical Devices
|
WO2006111198A1
(en)
*
|
2005-04-18 |
2006-10-26 |
Associazione Foresta Per La Ricerca Nella Riproduzione Umana |
Use of pde-5 inhibitors for endothelial repair of tissues impaired by trauma or disease
|
US9539410B2
(en)
|
2005-04-19 |
2017-01-10 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating post-cardial infarction damage
|
US8828433B2
(en)
*
|
2005-04-19 |
2014-09-09 |
Advanced Cardiovascular Systems, Inc. |
Hydrogel bioscaffoldings and biomedical device coatings
|
US20080125745A1
(en)
|
2005-04-19 |
2008-05-29 |
Shubhayu Basu |
Methods and compositions for treating post-cardial infarction damage
|
FR2889200B1
(fr)
*
|
2005-07-27 |
2008-01-04 |
Inst Vaisseaux Et Du Sang Ass |
Systeme marqueur cellulaire/ligand, ou le marqueur est du type eph, materiau cellulaire comprenant ce systeme, procede de preparation et utilisation proangiogenique
|
US20070065514A1
(en)
*
|
2005-09-22 |
2007-03-22 |
Howell Mark D |
Method for enhancing immune responses in mammals
|
US7652922B2
(en)
*
|
2005-09-30 |
2010-01-26 |
Mosaid Technologies Incorporated |
Multiple independent serial link memory
|
US20070100323A1
(en)
*
|
2005-10-31 |
2007-05-03 |
Ludwig Florian N |
Facilitation of endothelialization by in situ surface modification
|
EP1951864B1
(en)
*
|
2005-11-07 |
2014-05-07 |
Amorcyte, Inc. |
Compositions and methods of vascular injury repair
|
US9034316B2
(en)
*
|
2006-10-24 |
2015-05-19 |
Amorcyte, Llc |
Infarct area perfusion-improving compositions and methods of vascular injury repair
|
US8637005B2
(en)
|
2005-11-07 |
2014-01-28 |
Amorcyte, Inc. |
Compositions and methods of vascular injury repair
|
US20110076255A1
(en)
|
2005-11-07 |
2011-03-31 |
Pecora Andrew L |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
TW200734462A
(en)
|
2006-03-08 |
2007-09-16 |
In Motion Invest Ltd |
Regulating stem cells
|
US7732190B2
(en)
|
2006-07-31 |
2010-06-08 |
Advanced Cardiovascular Systems, Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
US9242005B1
(en)
*
|
2006-08-21 |
2016-01-26 |
Abbott Cardiovascular Systems Inc. |
Pro-healing agent formulation compositions, methods and treatments
|
US20080075690A1
(en)
*
|
2006-09-22 |
2008-03-27 |
Mark Douglas Howell |
Method for enhancing immune responses in mammals
|
US20100034794A1
(en)
*
|
2006-10-03 |
2010-02-11 |
Van Der Strate Barry W A |
Endothelial progenitor cell compositions and neovascularization
|
WO2008085229A2
(en)
*
|
2006-11-15 |
2008-07-17 |
Arteriocyte Inc. |
Cell-based therapies for treating liver disease
|
US8741326B2
(en)
|
2006-11-17 |
2014-06-03 |
Abbott Cardiovascular Systems Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
US9005672B2
(en)
|
2006-11-17 |
2015-04-14 |
Abbott Cardiovascular Systems Inc. |
Methods of modifying myocardial infarction expansion
|
US8192760B2
(en)
|
2006-12-04 |
2012-06-05 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating tissue using silk proteins
|
FR2909559B1
(fr)
*
|
2006-12-06 |
2012-09-07 |
Inst Vaisseaux Et Du Sang |
Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
|
WO2008077094A2
(en)
*
|
2006-12-19 |
2008-06-26 |
Children's Medical Center Corporation |
Methods for promoting neovascularization
|
US8137968B2
(en)
*
|
2007-02-28 |
2012-03-20 |
The Board Of Trustees Of The University Of Illinois |
Selected endothelial progenitor cells and methods for use
|
US8323968B2
(en)
*
|
2007-03-02 |
2012-12-04 |
National University Of Ireland, Galway |
Osteopontin for the prediction and treatment of cardiovascular diseases
|
US7632340B2
(en)
*
|
2007-03-07 |
2009-12-15 |
Hamilton Beach Brands, Inc. |
Air purifier for removing particles or contaminants from air
|
EP2163250B1
(en)
*
|
2007-05-18 |
2013-01-09 |
National University Corporation Asahikawa Medical University |
Anticancer therapy by transplanting vascular endothelial progenitor cells
|
EP2162189B1
(en)
*
|
2007-06-13 |
2012-03-07 |
Wake Forest University Health Sciences |
Methods of restoration of erectile function
|
US20090053208A1
(en)
*
|
2007-08-20 |
2009-02-26 |
Medtronic Vascular, Inc. |
Methods and Systems for Improving Tissue Perfusion
|
CA2709398C
(en)
|
2007-12-14 |
2017-11-07 |
The Cleveland Clinic Foundation |
Use of stromal cell-derived factor 1 for promoting wound healing
|
US11051733B2
(en)
|
2008-01-18 |
2021-07-06 |
Wake Forest University Health Sciences |
Isolating and purifying cells for therapy
|
US20090246179A1
(en)
*
|
2008-02-11 |
2009-10-01 |
The Cleveland Clinic Foundation |
Method of treating myocardial injury
|
US20100028311A1
(en)
*
|
2008-07-09 |
2010-02-04 |
Baxter International Inc. |
Using of scaffold comprising fibrin for delivery of stem cells
|
WO2010021993A1
(en)
|
2008-08-19 |
2010-02-25 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
|
US8951795B2
(en)
|
2009-04-07 |
2015-02-10 |
National University Corporation Asahikawa Medical University |
Revascularization cells derived from mononuclear cells, and method of inducing differentiation thereof
|
AU2010242780B2
(en)
|
2009-05-01 |
2016-04-21 |
Puregraft Llc |
Systems, methods and compositions for optimizing tissue and cell enriched grafts
|
BR112012004395B8
(pt)
|
2009-08-28 |
2021-05-25 |
Cleveland Clinic Found |
plasmídeo fator 1 derivado de célula de estroma (sdf-1) e preparação injetável compreendendo referido plasmídeo
|
KR20120100962A
(ko)
*
|
2009-10-02 |
2012-09-12 |
박스터 헬쓰케어 에스.에이. |
신장 손상을 치료하는데 사용하기 위한 조혈 줄기 세포
|
WO2011050266A1
(en)
|
2009-10-23 |
2011-04-28 |
Amorcyte, Inc. |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
DK3590949T3
(da)
|
2010-10-01 |
2022-07-11 |
Modernatx Inc |
Ribonukleinsyrer indeholdende n1-methyl-pseudouracil og anvendelse heraf
|
WO2012048298A2
(en)
|
2010-10-08 |
2012-04-12 |
Caridianbct, Inc. |
Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
|
NZ609567A
(en)
*
|
2010-11-05 |
2015-05-29 |
Transbio Ltd |
Markers of endothelial progenitor cells and uses thereof
|
EP2663868A2
(en)
|
2010-12-01 |
2013-11-20 |
The University of North Carolina at Chapel Hill |
Methods and compositions for targeting sites of neovascular growth
|
US8710200B2
(en)
|
2011-03-31 |
2014-04-29 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids encoding a modified erythropoietin and their expression
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
RU2648950C2
(ru)
|
2011-10-03 |
2018-04-02 |
Модерна Терапьютикс, Инк. |
Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
|
US9533010B2
(en)
|
2011-10-31 |
2017-01-03 |
Amorcyte, Llc |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
US20130156849A1
(en)
|
2011-12-16 |
2013-06-20 |
modeRNA Therapeutics |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
EP2817014A2
(en)
|
2012-02-21 |
2014-12-31 |
Baxter International Inc |
Pharmaceutical composition comprising cd34+ cells
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
US9303079B2
(en)
|
2012-04-02 |
2016-04-05 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
WO2013151667A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides
|
RS63237B1
(sr)
|
2012-11-26 |
2022-06-30 |
Modernatx Inc |
Terminalno modifikovana rnk
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
WO2015073913A1
(en)
|
2013-11-16 |
2015-05-21 |
Terumo Bct, Inc. |
Expanding cells in a bioreactor
|
US11008547B2
(en)
|
2014-03-25 |
2021-05-18 |
Terumo Bct, Inc. |
Passive replacement of media
|
CN106715676A
(zh)
|
2014-09-26 |
2017-05-24 |
泰尔茂比司特公司 |
按计划供养
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
CN109415696A
(zh)
|
2016-05-25 |
2019-03-01 |
泰尔茂比司特公司 |
细胞扩增
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
EP3601521A2
(en)
|
2017-03-31 |
2020-02-05 |
Terumo BCT, Inc. |
Cell expansion
|